title: Selective targeting of antibody conjugated multifunctional nanoclusters (nanoroses) to epidermal growth factor receptors in cancer cells.
abstract: The ability of smaller than 100 nm antibody (Ab) nanoparticle conjugates to target and modulate the biology of specific cell types may enable major advancements in cellular imaging and therapy in cancer. A key challenge is to load a high degree of targeting, imaging, and therapeutic functionality into small, yet stable particles. A versatile method called thin autocatalytic growth on substrate (TAGs) has been developed in our previous study to form ultrathin and asymmetric gold coatings on iron oxide nanocluster cores producing exceptional near-infrared (NIR) absorbance. AlexaFluor 488 labeled Abs were used to correlate the number of Abs conjugated to iron oxide/gold nanoclusters (nanoroses) with the hydrodynamic size. A transition from submonolayer to multilayer aggregates of Abs on the nanorose surface was observed for 54 Abs and an overall particle diameter of ∼60-65 nm. The hydrodynamic diameter indicated coverage of a monolayer of 54 Abs, in agreement with the prediction of a geometric model, by assuming a circular footprint of 16.9 nm diameter per Ab molecule. The targeting efficacy of nanoclusters conjugated with monoclonal Abs specific for epidermal growth factor receptor (EGFR) was evaluated in A431 cancer cells using dark field microscopy and atomic absorbance spectrometry (AAS) analysis. Intense NIR scattering was achieved from both high uptake of nanoclusters in cells and high intrinsic NIR absorbance of individual nanoclusters. Dual mode imaging with dark field reflectance microscopy and fluorescence microscopy indicates the Abs remained attached to the Au surfaces upon the uptake by the cancer cells. The ability to load intense multifunctionality, specifically strong NIR absorbance, conjugation of an Ab monolayer in addition to a strong r2 MRI contrast that was previously demonstrated in a total particle size of only 63 nm, is an important step forward in development of theranostic agents for combined molecular specific imaging and therapy.
authors: Department of Chemical Engineering, University of Texas at Austin, Austin, Texas 78712, USA.
authors: Li Leo
authors: LL
authors: Ma
authors: Justina O
authors: JO
authors: Tam
authors: Brian W
authors: BW
authors: Willsey
authors: Daniel
authors: D
authors: Rigdon
authors: Rajagopal
authors: R
authors: Ramesh
authors: Konstantin
authors: K
authors: Sokolov
authors: Keith P
authors: KP
authors: Johnston
references: ACS Nano. 2009 Sep 22;3(9):2686-96
references: 19711944
references: Biotechnol Bioeng. 2008 Dec 15;101(6):1214-22
references: 18980182
references: Protein Sci. 1998 Dec;7(12):2642-52
references: 9865959
references: ChemMedChem. 2008 Sep;3(9):1311-5
references: 18613203
references: Nanotechnology. 2013 Jan 18;24(2):025606
references: 23238021
references: J Immunol Methods. 1991 Nov 5;144(1):19-25
references: 1960403
references: Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):136-43
references: 14734462
references: J Biomed Opt. 2008 May-Jun;13(3):034024
references: 18601569
references: ACS Nano. 2010 Oct 26;4(10):5887-96
references: 20863096
references: J Biomed Opt. 2007 May-Jun;12(3):034007
references: 17614715
references: Nat Nanotechnol. 2007 Aug;2(8):495-9
references: 18654347
references: Langmuir. 2007 Aug 14;23(17):9050-6
references: 17629315
references: ACS Nano. 2009 Jun 23;3(6):1379-88
references: 19441794
references: Cancer Res. 2003 May 1;63(9):1999-2004
references: 12727808
references: Small. 2010 Feb 22;6(4):517-22
references: 20029850
references: Pharm Res. 2009 Jan;26(1):235-43
references: 18712584
references: ACS Nano. 2010 Mar 23;4(3):1521-8
references: 20146507
references: Int J Pharm. 2005 Jan 31;289(1-2):1-30
references: 15652195
references: Nano Lett. 2009 Oct;9(10):3612-8
references: 19645464
references: Nano Lett. 2006 Apr;6(4):827-32
references: 16608292
references: Nano Lett. 2005 Apr;5(4):709-11
references: 15826113
references: Langmuir. 2009 Oct 6;25(19):11777-85
references: 19711913
references: Nanomedicine (Lond). 2010 Jun;5(4):523-8
references: 20528447
references: Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11613-8
references: 18697944
references: Trends Immunol. 2006 Dec;27(12):573-9
references: 17049307
references: J Clin Oncol. 2005 Apr 10;23(11):2445-59
references: 15753456
references: Nat Nanotechnol. 2008 Mar;3(3):131-2
references: 18654480
references: Angew Chem Int Ed Engl. 2009;48(1):60-103
references: 19053095
references: J Am Chem Soc. 2006 Feb 15;128(6):2115-20
references: 16464114
references: J Am Chem Soc. 2009 Aug 12;131(31):11174-8
references: 19603808
references: Nat Nanotechnol. 2008 Mar;3(3):145-50
references: 18654486
references: Int Immunopharmacol. 2003 Mar;3(3):319-28
references: 12639809
references: Langmuir. 2009 Dec 1;25(23):13384-93
references: 19928938
references: Cancer Res. 1986 Dec;46(12 Pt 1):6387-92
references: 2946403
references: Technol Cancer Res Treat. 2004 Dec;3(6):647-57
references: 15560723
references: Adv Drug Deliv Rev. 2006 Dec 1;58(14):1456-9
references: 17070960
references: Nano Lett. 2007 Oct;7(10):3065-70
references: 17854227
references: Methods Enzymol. 1983;93:280-333
references: 6346011
references: Nat Biotechnol. 2008 Jan;26(1):83-90
references: 18157119
references: Bioconjug Chem. 2002 May-Jun;13(3):554-60
references: 12009946
references: Immunol Lett. 1984;8(5):273-7
references: 6394473
references: Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):11901-4
references: 17620615
references: Nat Protoc. 2008;3(2):314-20
references: 18274533
references: Clin Cancer Res. 1995 Nov;1(11):1311-8
references: 9815926
references: Nat Rev Cancer. 2005 Mar;5(3):161-71
references: 15738981
references: Acta Biochim Pol. 2002;49(2):387-91
references: 12362980
references: Opt Express. 2006 Dec 25;14(26):12930-43
references: 19532186
references: Cancer Res. 2003 Nov 15;63(22):7870-5
references: 14633715
references: Nano Lett. 2009 Aug;9(8):2825-31
references: 19572747
references: Oncogene. 2000 Nov 20;19(49):5548-57
references: 11114734
references: J Am Chem Soc. 2007 Jul 18;129(28):8698-9
references: 17590000
references: Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13549-54
references: 14597719
references: Nano Lett. 2007 May;7(5):1338-43
references: 17439187
references: Science. 2006 May 26;312(5777):1168-71
references: 16728630